Profil
Frank M.
Longo is the founder of PharmatrophiX, Inc., which was founded in 2005.
He holds the title of Chairman at PharmatrophiX, Inc. Dr. Longo is currently working at Stanford University, where he has been Chairman-Neurology & Neurological Sciences since 2006.
In terms of education, Dr. Longo obtained a doctorate degree from the University of California San Diego in 1981 and another doctorate degree in 1983.
He also has a graduate degree from Harvard T.H.
Chan School of Public Health.
Postes actifs de Frank M. Longo
| Sociétés | Poste | Début |
|---|---|---|
PharmatrophiX, Inc.
 PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Founder | 01/01/2005 |
| Stanford University | Corporate Officer/Principal | 01/01/2006 |
Formation de Frank M. Longo
| University of California San Diego | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
PharmatrophiX, Inc.
PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
